1. Les nouveaux traitements médicaux de l'endométriose.
- Author
-
Bouet, Pierre-Emmanuel, Delbos, Léa, Descamps, Philippe, and Legendre, Guillaume
- Subjects
- *
ENDOMETRIOSIS , *THERAPEUTICS , *GONADOTROPIN releasing hormone , *ESTROGEN , *PROGESTATIONAL hormones , *MENINGIOMA - Abstract
The medical management of painful endometriosis is essentially based on anti-gonadotropic molecules and analgesics in the absence of a desire for pregnancy on the part of the patients, and constitutes the first therapeutic step. Dienogest, a recent treatment, has found its place in the management algorithm for painful endometriosis in view of its proven efficacy. It is recommended as a second-line treatment. The ANSM has very recently (March 2023) issued recommendations aimed at controlling the risk of meningioma for various progestogens including dienogest. Relugolix Combination Therapy, which combines a GnRH antagonist and an estrogen-progestin addback therapy in a single tablet, appears to be a promising treatment for painful endometriosis and the initial data on the safety of the treatment (after 6 months of use) are reassuring. Today, anti-aromatases, SERMs or selective inhibitors cannot be considered as an alternative therapy in the medical treatment of painful endometriosis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF